Telesis Bio Inc. (TBIO) Nonoperating Income (Expense) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD and USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Telesis Bio Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
  • Telesis Bio Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$114 K, a 21.4% increase year-over-year.
  • Telesis Bio Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$1.13 M, a 36.6% increase year-over-year.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2023 was -$1.16 M, a 40.8% increase from 2022.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2022 was -$1.96 M, a 45% increase from 2021.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2021 was -$3.57 M, a 117% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.13 M -$114 K +$31 K +21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.16 M -$203 K +$39 K +16.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$1.2 M -$496 K +$561 K +53.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.76 M -$317 K +$21 K +6.21% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$1.78 M -$145 K +$180 K +55.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.96 M -$242 K +$148 K +37.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$2.11 M -$1.06 M -$678 K -179% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.43 M -$338 K +$1.29 M +79.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$2.72 M -$325 K +$849 K +72.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$3.57 M -$390 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$379 K -$216 K -133% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.63 M -$841 K -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$1.17 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$163 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$786 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.